4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-099351
Chief Executive Officer bought 1,000 shares at an average $6.22 ($6,215)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2024-08-19 | Purchase | +500 | $6.31 | $3,155 | 565,043 | D |
| Barrow Robert Chief Executive Officer | 2024-08-20 | Purchase | +500 | $6.12 | $3,060 | 565,543 | D |
| Open-market purchases · 1,000 sh · avg $6.22 · $6,215 | |||||||
Loading xslF345X05/ownership.xml…